EUVIMEDEUVIMED entdecken
Crossref

Outcomes and prognostic factors associated with relapse after haploidentical stem cell transplantation for paediatric T‐cell acute lymphoblastic leukaemia

Chen Zhao, Meng-Yu Xiao iD, Feng Zhang, Lu Bai, Guan-Hua Hu, Pan Suo, Feng-Rong Wang, Zhi-Dong Wang, Xiao-Dong Mo, Yu Wang, Yuan-Yuan Zhang, Lan-Ping Xu und 3 weitere

British Journal of Haematology · 2025-04 · 206 (4) · 1165-1172

DOI: 10.1111/bjh.20007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 24.02.2025. Verfasst von Chen Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, National Clinical Research Center f…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Transplantation, Haploidentical. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Key Program of National Natural Science Foundation of China, Capital Health Development and Research of Special.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The outcomes are poor for paediatric patients with T‐cell acute lymphoblastic leukaemia (T‐ALL) who relapse after haematopoietic stem cell transplantation (HSCT). However, studies focusing on paediatric patients with T‐ALL following haploidentical HSCT (haplo‐HSCT) are limited. We retrospectively identified a consecutive cohort comprising of 128 paediatric T‐ALL after haplo‐HSCT from 2642 consecutive ALL patients between January 2010 and June 2022. The 2‐year overall survival and leukaemia‐free survival were 67.77% ± 4.21% and 66.34% ± 3.82%, respectively, and the cumulative incidence of relapse (CIR) and non‐relapse mortality were 33.82% ± 0.70% and 12.65% ± 0.46% respectively. According to the multivariate Cox regression analysis, CD34 cells, minimal residual disease (MRD) ≥0.01% before HSCT, chronic graft‐versus‐host disease (cGvHD) and cytomegalovirus were associated with relapse ( p < 0.05). To develop a scoring system for stratifying patients, we combined the variables and stratified them into low (0–2 points) and high (3, 4) groups. Consequently, the 2‐year CIR in low and high groups were 23.76% ± 1.83% and 48.22% ± 2.42% ( p = 0.009), respectively. Children with T‐ALL have poor long‐term survival, and haplo‐HSCT is a potent and safe treatment; however, the incidence of relapse is high. Eliminating pre‐HSCT MRD, guaranteeing sufficient CD34 cells infusion and the occurrence of cGvHD and cytomegalovirus reactivation may benefit from relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationPrecursor T-Cell Lymphoblastic Leukemia-LymphomaTransplantation, HaploidenticalHumansChildMaleFemaleChild, PreschoolAdolescentRetrospective StudiesPrognosisRecurrenceGraft vs Host DiseaseInfantTreatment OutcomeNeoplasm, ResidualSurvival Rate

Stichwörter der Autor:innen

haploidentical stem cell transplantationpaediatric T‐cell acute lymphoblastic leukaemiarelapse

Autor:innen und Institutionen

  • Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking Un…

ORCID-Profile: Meng-Yu Xiao, Xiao-Hui Zhang

Förderung

  • National Key Research and Development Program of China
  • Key Program of National Natural Science Foundation of China
  • Capital Health Development and Research of Special
  • Beijing Natural Science Foundation
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Zhao, C., Xiao, M. Y., Zhang, F., Bai, L., Hu, G. H., Suo, P., Wang, F. R., Wang, Z. D., Mo, X. D., Wang, Y., Zhang, Y. Y., Xu, L. P., Huang, X. J., Cheng, Y. F., & Zhang, X. H. (2025). Outcomes and prognostic factors associated with relapse after haploidentical stem cell transplantation for paediatric T‐cell acute lymphoblastic leukaemia. British Journal of Haematology, 206(4), 1165-1172. https://doi.org/10.1111/bjh.20007

Vancouver

Zhao C, Xiao MY, Zhang F, Bai L, Hu GH, Suo P, et al. Outcomes and prognostic factors associated with relapse after haploidentical stem cell transplantation for paediatric T‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 2025;206(4):1165-1172. doi:10.1111/bjh.20007

BibTeX
@article{Zhao2025,
  author = {Zhao, Chen and Xiao, Meng-Yu and Zhang, Feng and Bai, Lu and Hu, Guan-Hua and Suo, Pan and Wang, Feng-Rong and Wang, Zhi-Dong and Mo, Xiao-Dong and Wang, Yu and Zhang, Yuan-Yuan and Xu, Lan-Ping and Huang, Xiao-Jun and Cheng, Yi-Fei and Zhang, Xiao-Hui},
  title = {Outcomes and prognostic factors associated with relapse after haploidentical stem cell transplantation for paediatric T‐cell acute lymphoblastic leukaemia},
  journal = {British Journal of Haematology},
  year = {2025},
  volume = {206},
  number = {4},
  pages = {1165--1172},
  doi = {10.1111/bjh.20007}
}
Kostenlos starten →